KRYS
Krystal Biotech·NASDAQ
--
--(--)
--
--(--)
2.86 / 10
Underperform
KRYS's fundamental assessment is subpar, scoring only 2.9/10. Key weaknesses include low asset-to-market value (-0.5007) and a high net profit-to-total profit ratio (110.91%), both of which place the company in the least favorable quartile. Revenue-MV (-1.7549) and Profit-MV (0.3940) are in quartile 1, suggesting limited scale advantages. However, strong gross margin (94.16%) and Cash-MV (-1.1774) in quartile 1 hint at operational efficiency in converting sales to cash. Overall, the fundamental picture is challenging, supporting a prudent investment stance.
Analysis Checks(7/10)
Revenue-MV
Value-1.75
Score2/3
Weight29.79%
1M Return11.69%
Value-1.75
Score2/3
Weight29.79%
1M Return11.69%
Gross profit margin (%)
Value94.16
Score2/3
Weight3.23%
1M Return1.47%
Value94.16
Score2/3
Weight3.23%
1M Return1.47%
PB-ROE
Value3.07
Score2/3
Weight27.44%
1M Return10.68%
Value3.07
Score2/3
Weight27.44%
1M Return10.68%
Fixed assets turnover ratio
Value1.77
Score2/3
Weight0.25%
1M Return0.12%
Value1.77
Score2/3
Weight0.25%
1M Return0.12%
Cash-MV
Value-1.18
Score2/3
Weight19.57%
1M Return7.73%
Value-1.18
Score2/3
Weight19.57%
1M Return7.73%
Inventory turnover ratio
Value0.51
Score2/3
Weight-4.96%
1M Return-2.63%
Value0.51
Score2/3
Weight-4.96%
1M Return-2.63%
Profit-MV
Value0.39
Score2/3
Weight19.55%
1M Return7.79%
Value0.39
Score2/3
Weight19.55%
1M Return7.79%
Current assets turnover ratio
Value0.34
Score1/3
Weight-0.99%
1M Return-0.48%
Value0.34
Score1/3
Weight-0.99%
1M Return-0.48%
Asset-MV
Value-0.50
Score0/3
Weight6.68%
1M Return2.94%
Value-0.50
Score0/3
Weight6.68%
1M Return2.94%
Net profit / Total profit (%)
Value110.91
Score0/3
Weight-0.58%
1M Return-0.30%
Value110.91
Score0/3
Weight-0.58%
1M Return-0.30%
Revenue-MV
Value-1.75
Score2/3
Weight29.79%
1M Return11.69%
Value-1.75
Score2/3
Weight29.79%
1M Return11.69%
Inventory turnover ratio
Value0.51
Score2/3
Weight-4.96%
1M Return-2.63%
Value0.51
Score2/3
Weight-4.96%
1M Return-2.63%
Gross profit margin (%)
Value94.16
Score2/3
Weight3.23%
1M Return1.47%
Value94.16
Score2/3
Weight3.23%
1M Return1.47%
Profit-MV
Value0.39
Score2/3
Weight19.55%
1M Return7.79%
Value0.39
Score2/3
Weight19.55%
1M Return7.79%
PB-ROE
Value3.07
Score2/3
Weight27.44%
1M Return10.68%
Value3.07
Score2/3
Weight27.44%
1M Return10.68%
Current assets turnover ratio
Value0.34
Score1/3
Weight-0.99%
1M Return-0.48%
Value0.34
Score1/3
Weight-0.99%
1M Return-0.48%
Fixed assets turnover ratio
Value1.77
Score2/3
Weight0.25%
1M Return0.12%
Value1.77
Score2/3
Weight0.25%
1M Return0.12%
Asset-MV
Value-0.50
Score0/3
Weight6.68%
1M Return2.94%
Value-0.50
Score0/3
Weight6.68%
1M Return2.94%
Cash-MV
Value-1.18
Score2/3
Weight19.57%
1M Return7.73%
Value-1.18
Score2/3
Weight19.57%
1M Return7.73%
Net profit / Total profit (%)
Value110.91
Score0/3
Weight-0.58%
1M Return-0.30%
Value110.91
Score0/3
Weight-0.58%
1M Return-0.30%
Is KRYS undervalued or overvalued?
- KRYS scores 2.86/10 on fundamentals and holds a Premium valuation at present. Backed by its 14.72% ROE, 53.30% net margin, 53.90 P/E ratio, 6.95 P/B ratio, and 272.97% earnings growth, these metrics solidify its Underperform investment rating.
